AI assistant
AtriCure, Inc. — Director's Dealing 2020
Jan 17, 2020
31802_dirs_2020-01-17_86b5a9ac-9115-47a3-a537-5c9e95eb3c0c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2020-01-15
Reporting Person: Collar Mark A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-01-15 | Common Stock | S | 4000 | $35.02 | Disposed | 77106 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5300 | Indirect |
Footnotes
F1: These shares were sold pursuant to a 10b5-1 trading plan.
F2: This transaction was executed in multiple trades at prices ranging from $35.00 to $35.09 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: The Reporting Person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.